MediWound (MDWD) Treasury Shares (2013 - 2014)

MediWound (MDWD) recorded quarterly Treasury Shares of -$34.6 million in Q1 2014, little changed quarter-over-quarter from -$34.6 million in Q4 2013.

MediWound (MDWD) Treasury Shares (2013 - 2014) Analysis & Trends

MediWound's Treasury Shares history runs 2 years deep, the most recent figure standing at -$34.6 million for Q1 2014.

In Q1 2014, Treasury Shares changed N/A year-over-year to -$34.6 million; the TTM figure through Mar 2014 stood at -$34.6 million (changed N/A YoY), while the FY2013 annual figure was -$34.6 million, changed N/A from the prior year.
Treasury Shares was -$34.6 million for Q1 2014 at MediWound, roughly flat from -$34.6 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of -$34.6 million in Q3 2013 to a low of -$34.6 million in Q3 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	700,000.00
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	MediWound	3.70 Mn	3.70 Mn	278,000.00	-

Download Data